Invention Grant
- Patent Title: Basal titration with adaptive target glucose level
-
Application No.: US17687201Application Date: 2022-03-04
-
Publication No.: US12109392B2Publication Date: 2024-10-08
- Inventor: Tinna Bjoerk Aradottir , Henrik Bengtsson , Morten Lind Jensen , Pete Brockmeier
- Applicant: Novo Nordisk A/S
- Applicant Address: DK Bagsvaerd
- Assignee: Novo Nordisk A/S
- Current Assignee: Novo Nordisk A/S
- Current Assignee Address: DK Bagsvaerd
- Agent Wesley Nicolas
- Priority: EP 178877 2017.06.29 EP 190146 2017.09.08
- Main IPC: A61M5/172
- IPC: A61M5/172 ; G16H20/17 ; A61M5/142

Abstract:
Systems and methods are provided for adjusting long acting insulin medicament dosages for a subject. A plurality of timestamped glucose measurements of the subject is obtained. A titration glucose level (246) is computed as a measure of central tendency (244, 268, 274) of a titration subset of small glucose measurements (240, 269, 273) identified within the timestamped glucose measurements, wherein the measure of central tendency represents a measure of small glucose measurements for the primary time window. A long acting insulin medicament dosage (216) is adjusted or maintained based upon the obtained titration glucose level (246).
Public/Granted literature
- US20220184310A1 BASAL TITRATION WITH ADAPTIVE TARGET GLUCOSE LEVEL Public/Granted day:2022-06-16
Information query
IPC分类: